Calidi Biotherapeutics, Inc. (CLDI) Operating income 2022–2025
Calidi Biotherapeutics, Inc. (CLDI) annual operating income history from SEC filings — each fiscal year as reported.
-$20.2MFY2025 · since FY2022: -$23.1M → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | +7.1% |
| FY2024 | -$21.8M | +24.9% |
| FY2023 | -$29.0M | -25.4% |
| FY2022 | -$23.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLDI financial trends
CLDI RevenueCLDI Net incomeCLDI Net marginCLDI Gross profitCLDI Gross marginCLDI Operating marginCLDI Operating cash flowCLDI Free cash flowCLDI Capital expendituresCLDI Return on equityCLDI Stock buybacksCLDI Dividends paidCLDI Total assetsCLDI Total liabilitiesCLDI Shareholders’ equityCLDI overview →